On this page
Mirtazapine
Active ingredient 5 prescription 14 with labelling
Overview
Source: NDC DirectoryIngredient name
MIRTAZAPINE
Base moiety
MIRTAZAPINE
RxNorm CUI
UNII
A051Q2099Q
Medication products
8
Brand names
3
Dosage forms
4
FAERS reports
91,059 · not a risk measure
- Mirtazapine Powder
- Mirtazapine (Process-II) Powder
- Mirtazapine Anhydrous Powder
- Mirtazapine Tablet
- Mirtazapine Tablet, Film Coated
- Mirtazapine Tablet, Orally Disintegrating
- REMERON Mirtazapine · Tablet, Film Coated
- REMERONSOLTAB Mirtazapine · Tablet, Orally Disintegrating
Entries without a link are products listed by the FDA that carry no approval record, therapeutic equivalence rating or official labelling, so they have no detail page. Their facts are shown inline.
By dosage form
| Dosage form | Products | Examples |
|---|---|---|
| Powder | 3 | Mirtazapine, Mirtazapine (Process-II), Mirtazapine Anhydrous |
| TABLET, Film Coated | 2 | Mirtazapine, REMERON |
| TABLET, Orally Disintegrating | 2 | Mirtazapine, REMERONSOLTAB |
| Tablet | 1 | Mirtazapine |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Ingredient name, strengths, products, labelers, packages |
| DailyMed RxNorm mappings | NLM | RxNorm concept identifier (RxCUI) |
| FAERS | FDA | Adverse event report totals |